Operating Lease, Right-of-Use Asset of Pulmonx Corp from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pulmonx Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Pulmonx Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $18,279,000, a 0.24% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Pulmonx Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $18,279,000 +$43,000 +0.24% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $18,643,000 +$153,000 +0.83% 30 Jun 2025 10-Q 01 Aug 2025 2025 Q2
Q1 2025 $18,682,000 +$15,977,000 +591% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $18,545,000 +$15,139,000 +444% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $18,236,000 +$14,175,000 +349% 30 Sep 2024 10-Q 01 Nov 2024 2024 Q3
Q2 2024 $18,490,000 +$13,784,000 +293% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $2,705,000 -$2,447,000 -47% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $3,406,000 -$2,400,000 -41% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $4,061,000 -$2,345,000 -37% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $4,706,000 -$2,281,000 -33% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $5,152,000 -$2,366,000 -31% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $5,806,000 -$2,269,000 -28% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $6,406,000 -$2,068,000 -24% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $6,987,000 -$840,000 -11% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $7,518,000 -$886,000 -11% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $8,075,000 -$901,000 -10% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $8,474,000 -$1,015,000 -11% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $7,827,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $8,404,000 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $8,976,000 +$2,415,000 +37% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $9,489,000 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q4 2019 $6,561,000 31 Dec 2019 10-K 15 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.